Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels

Clinical trial NCT01678313 · COMPLETED

Trial details

NCT number: NCT01678313
Sponsor: Buddhist Tzu Chi General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2012-08-01
Primary completion: 2013-08-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.